Genome exploration through toxin-mediated ribosome stalling
通过毒素介导的核糖体停滞进行基因组探索
基本信息
- 批准号:10616690
- 负责人:
- 金额:$ 38.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-05-07 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAntibioticsBacteriaBiologicalCellsCharacteristicsChemicalsCodon NucleotidesComputer AnalysisConsensus SequenceDataData SetDevelopmentDiagnosticDiseaseEndoribonucleasesEventExclusionExhibitsFamily memberGeneticGenomeGrowthHIVHarvestHumanImmuneImmune responseImmune systemIndividualInfectionM. tuberculosis genomeMapsMass Spectrum AnalysisMediatingMethodsMolecularMycobacterium tuberculosisOpen Reading FramesOperative Surgical ProceduresPathogenesisPathway interactionsPeptidesPersonsPhysiologyPositioning AttributeProcessProteinsProteomeProteomicsRNAResearchResourcesRibosomal RNARibosomesRiskSamplingSeriesSiteSpecificityStressSystemTechnologyTherapeuticTimeToxinTranscriptTransfer RNATreatment ProtocolsTuberculosisannotation systemantimicrobialantitoxinassaultcell growthcellular targetingeffective therapygenome annotationgenome-wideimprovedlatent infectionnovelpathogenresponserib bone structureribosome profilingscreeningtooltool developmenttranscriptome sequencing
项目摘要
Project Summary
Approximately 90% of individuals infected with Mycobacterium tuberculosis (Mtb) develop an asymptomatic
latent infection, which is non-infectious. Although some individuals may eradicate this infection, those who do
not comprise a large reservoir of persons who can convert from latent to active TB, which is infectious.
Reactivation is especially likely in immune-compromised individuals, including those infected with HIV. The
molecular switches that enable Mtb to slow or stop replication, become dormant and establish latent TB infection
are poorly characterized. A thorough understanding of these switches is critical for development of 1) diagnostics
to enable prediction of reactivation risk and 2) shorter, more effective treatment regimens for latent TB infection.
Toxin-antitoxin (TA) systems are strongly implicated in establishment of latent TB infection because their toxin
components typically downregulate Mtb cell growth and are activated in response to stresses relevant to this
state. Yet, the extraordinary redundancy of TA systems make determination of the individual contributions of
each toxin challenging using conventional genetic and molecular biological approaches. We propose to use a
powerful battery of genome-scale tools to track the fate of transcripts, ribosomes and proteins in response to
activation of a subset of tRNA-cleaving toxins to understand the molecular mechanisms that underlie stress
survival. We then exploit our finding that the codon-specific ribosome-stalling characteristic of these toxins
identifies novel ORFs and apply this as a reliable tool for improved Mtb genome annotation.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NANCY ANN WOYCHIK其他文献
NANCY ANN WOYCHIK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NANCY ANN WOYCHIK', 18)}}的其他基金
Repurposing Mycobacterium tuberculosis tRNase toxins for cancer chemotherapy
重新利用结核分枝杆菌 tRNase 毒素进行癌症化疗
- 批准号:
10532244 - 财政年份:2021
- 资助金额:
$ 38.38万 - 项目类别:
Repurposing Mycobacterium tuberculosis tRNase toxins for cancer chemotherapy
重新利用结核分枝杆菌 tRNase 毒素进行癌症化疗
- 批准号:
10354376 - 财政年份:2021
- 资助金额:
$ 38.38万 - 项目类别:
Genome exploration through toxin-mediated ribosome stalling
通过毒素介导的核糖体停滞进行基因组探索
- 批准号:
10396107 - 财政年份:2020
- 资助金额:
$ 38.38万 - 项目类别:
Genome exploration through toxin-mediated ribosome stalling
通过毒素介导的核糖体停滞进行基因组探索
- 批准号:
10159845 - 财政年份:2020
- 资助金额:
$ 38.38万 - 项目类别:
Proteome reprogramming by tRNA-cleaving toxins
通过 tRNA 裂解毒素进行蛋白质组重编程
- 批准号:
10112828 - 财政年份:2020
- 资助金额:
$ 38.38万 - 项目类别:
Genome exploration through toxin-mediated ribosome stalling
通过毒素介导的核糖体停滞进行基因组探索
- 批准号:
10034312 - 财政年份:2020
- 资助金额:
$ 38.38万 - 项目类别:
Transcriptome and proteome remodeling by Mycobacterium tuberculosis MazF toxins
结核分枝杆菌 MazF 毒素的转录组和蛋白质组重塑
- 批准号:
10307528 - 财政年份:2019
- 资助金额:
$ 38.38万 - 项目类别:
Transcriptome and proteome remodeling by Mycobacterium tuberculosis MazF toxins
结核分枝杆菌 MazF 毒素的转录组和蛋白质组重塑
- 批准号:
10062823 - 财政年份:2019
- 资助金额:
$ 38.38万 - 项目类别:
Transcriptome and proteome remodeling by Mycobacterium tuberculosis MazF toxins
结核分枝杆菌 MazF 毒素的转录组和蛋白质组重塑
- 批准号:
10530645 - 财政年份:2019
- 资助金额:
$ 38.38万 - 项目类别:
Transcriptome and proteome remodeling by Mycobacterium tuberculosis MazF toxins
结核分枝杆菌 MazF 毒素的转录组和蛋白质组重塑
- 批准号:
9886870 - 财政年份:2019
- 资助金额:
$ 38.38万 - 项目类别:
相似海外基金
DYNBIOTICS - Understanding the dynamics of antibiotics transport in individual bacteria
DYNBIOTICS - 了解抗生素在单个细菌中转运的动态
- 批准号:
EP/Y023528/1 - 财政年份:2024
- 资助金额:
$ 38.38万 - 项目类别:
Research Grant
Engineering Streptomyces bacteria for the sustainable manufacture of antibiotics
工程化链霉菌用于抗生素的可持续生产
- 批准号:
BB/Y007611/1 - 财政年份:2024
- 资助金额:
$ 38.38万 - 项目类别:
Research Grant
Hitting bacteria with a Bam: Lectin-Like Antimicrobials as New Antibiotics
用 Bam 击中细菌:凝集素类抗菌剂作为新型抗生素
- 批准号:
DP230102150 - 财政年份:2023
- 资助金额:
$ 38.38万 - 项目类别:
Discovery Projects
Systematic identification of synthetic interactions in bacteria towards the next-generation of antibiotics
系统鉴定细菌与下一代抗生素的合成相互作用
- 批准号:
468567 - 财政年份:2022
- 资助金额:
$ 38.38万 - 项目类别:
Operating Grants
“L-form” bacteria: basic science, antibiotics, evolution and biotechnology
L 型细菌:基础科学、抗生素、进化和生物技术
- 批准号:
FL210100071 - 财政年份:2022
- 资助金额:
$ 38.38万 - 项目类别:
Australian Laureate Fellowships
Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants
使用抗生素佐剂重新利用革兰氏阳性抗生素治疗革兰氏阴性菌
- 批准号:
10708102 - 财政年份:2022
- 资助金额:
$ 38.38万 - 项目类别:
Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants
使用抗生素佐剂重新利用革兰氏阳性抗生素治疗革兰氏阴性菌
- 批准号:
10587015 - 财政年份:2022
- 资助金额:
$ 38.38万 - 项目类别:
Isolation, identification and characterization of potentially novel antibiotics from rhizospheric bacteria without detectable in vitro resistance
从根际细菌中分离、鉴定和表征潜在的新型抗生素,且体外未检测到耐药性
- 批准号:
10581945 - 财政年份:2021
- 资助金额:
$ 38.38万 - 项目类别:
Developing novel antibiotics from natural products against resistant bacteria
从天然产物中开发针对耐药细菌的新型抗生素
- 批准号:
2599490 - 财政年份:2021
- 资助金额:
$ 38.38万 - 项目类别:
Studentship
Isolation, identification and characterization of potentially novel antibiotics from rhizospheric bacteria without detectable in vitro resistance
从根际细菌中分离、鉴定和表征潜在的新型抗生素,且体外未检测到耐药性
- 批准号:
10358855 - 财政年份:2021
- 资助金额:
$ 38.38万 - 项目类别: